The MOD Pod

Carlo J. Pelino, OD, FAAO, hosts this special edition of the MODPod and speaks with guests Carolyn Majcher, OD, and Mohammad Rafieetary, OD, FAAO, FORS, Dipl ABO, ABCMO. The panel of expert optometrists discusses how to approach patients with age-related macular degeneration (AMD) in the early and intermediate stages of the disease. They also emphasize the value of imaging technology such as OCT and OCTA to recognize biomarkers for AMD, and they share approaches to diagnosing geographic atrophy (GA). This podcast is sponsored by ZEISS.

This month on The MOD Pod Alissa Coyne, OD, MS, FAAO, FASOS, provides an overview of monoclonal antibodies commonly encountered by optometrists, including side effects to be on the lookout for (1:16). Keeping with the pharmaceutical theme, Cecelia Koetting, OD, FAAO, Dipl ABO, closes the episode with a review of the potential harms and benefits associated with hormone replacement therapy, which is becoming increasingly more common (13:20).

This retina-focused episode starts off with an informative piece by Fraser McKay, OD, who offers tips for comanaging patients following vitrectomy from the early postoperative period on (00:43). Next, Taia DeLano, OD, FAAO, explains how using prism can redirect how light hits the retina and improve visual function (20:49). Naureen M. Haroon, OD, MPH, FAAO, takes us off topic to end the episode, with her guide for identifying eye- and vision-related changes in pregnant and postpartum patients and supporting their needs (30:17). 

In this special edition episode of The MOD Pod, David Kading, OD, FAAO, FCLSA, and Elise Kramer, OD, FAAO, FSLS, share their experiences using AvaGen™, The Genetic Eye Test, as a diagnostic and decision-making tool in the myopia management setting. Both doctors offer useful insights and discuss patient cases where genetic testing helped inform their treatment decision.

Check out this great episode of The MOD Pod! Lori Latowski Grover, OD, PhD, kicks things off with an overview of the current state of health equity because access to quality health care is still not a guarantee for all (00:55). Justin Schweitzer, OD, FAAO, follows with some considerations to keep in mind when caring for patients with glaucoma who require cataract surgery (09:44). Tying a nice bow on this episode is Joshua Davidson, OD, FAAO, FSLS, with his guide for distinguishing characteristics to help you make the right diagnosis between bacterial conjunctivitis or something else. (15:22). 

Sumit (Sam) Garg, MD, and Brandon Ayres, MD, discuss how they use AvaGen™, The Genetic Eye Test, to inform patients about their genetic risk of developing keratoconus and other corneal dystrophies, and the role it plays in helping them decide appropriate treatment.

Join this season’s expert panel of Laura Periman, MD; Carly Rose, OD; and Edward Jaccoma, MD, as they showcase a selection of interesting cases across the ocular surface spectrum. 

Tune in to hear Nate R. Lighthizer, OD, FAAO, examine the evolving role of laser in eye care (00:55). Then, listen as Thomas Cheezum, OD, CPC, addresses some common billing and coding questions related to the care of glaucoma patients (11:31) and Jerry Robben, OD, talks about discussing out-of-pocket expenses with patients (17:20). 

Tune in to hear Roxanne Achong-Coan, OD, FAAO, FIAOMC, FSLS, walk through the different considerations when first fitting medically necessary contact lenses (00:48). Then listen as Jason Schmit, OD, fills you in on what you need to know to manage thyroid eye disease (10:15) and Patricia Fulmer, OD, FAAO, offers helpful approaches that can prevent or navigate common misunderstandings that arise when dealing with patients who are wrong (18:58). 

Myranda Partin, OD, discusses the most commonly used therapies for meibomian gland dysfunction and relevant CPT codes associated with each (0:43). Christopher Kuc, OD, FAAO, then shares his five rules of thumb for managing the ocular surface (9:03), and Hardeep Kataria, OD, FAAO, and Mahnia Madan, OD, FAAO, wrap up the episode with some effective education strategies for nonadherent patients (19:06).